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Background: Although numerous studies have examined the role of latent
predispositions to internalizing and externalizing disorders in the structure of
comorbidity among common mental disorders, none examined latent predis-
positions in predicting development of comorbidity. Methods: A novel method
was used to study the role of latent variables in the development of comorbidity
among lifetime DSM-IV disorders in the National Comorbidity Surveys. Broad
preliminary findings are briefly presented to describe the method. The method
used survival analysis to estimate time-lagged associations among 18 lifetime
DSM-IV anxiety, mood, behavior, and substance disorders. A novel estimation
approach examined the extent to which these predictive associations could be
explained by latent canonical variables representing internalizing and
externalizing disorders. Results: Consistently significant positive associations
were found between temporally primary and secondary disorders. Within-
domain time-lagged associations were generally stronger than between-domain
associations. The vast majority of associations were explained by a model that
assumed mediating effects of latent internalizing and externalizing variables,
although the complexity of this model differed across samples. A number of
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Conclusions: The good fit of the canonical model suggests that common causal
pathways account for most comorbidity among the disorders considered. These
common pathways should be the focus of future research on the development of
comorbidity. However, the existence of several important residual associations
shows that more is involved than simple mediation. The method developed to
carry out these analyses provides a unique way to pinpoint these significant
residual associations for subsequent focused study. Depression and Anxiety
28:29–39, 2011. r r 2011 Wiley-Liss, Inc.
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INTRODUCTION
Comorbidity is the norm among common mental
disorders, as more than 50% of people with a mental
disorder in a given year meet criteria for two or
more disorders.[1,2] The structure of this comorbidity
has been the subject of considerable interest over the
past decade. Beginning with an influential paper by
Krueger,[3] numerous researchers have documented
that bivariate associations among hierarchy-free anxiety,
mood, behavior, and substance disorders can be
accounted for by correlated latent predispositions to
internalizing and externalizing disorders with division of
the internalizing dimension into secondary dimensions
of fear (e.g., panic and phobia) and distress (e.g., major
depressive episode and generalized anxiety disorder,
GAD).[4–9]
These results have been used to argue for a
reorganization of the classification of mental disorders
in the DSM and ICD diagnostic systems.[10–14]
However, some data suggest that this theoretical
structure is insufficiently robust to serve as the basis
for such a reorganization.[4,15] For example, the
distinction between fear and distress disorders emerges
in some samples but not in others[4,15–17] and the model
fit deteriorates when additional disorders are added or
when the model is estimated separately among people
at different life-course stages.[13,15] Nonetheless, the
results regarding latent variable associations can be
useful in investigating the extent to which risk factors
for individual disorders are more accurately concep-
tualized as risk factors for broad predispositions to
multiple disorders, as modeled by the latent dimen-
sions underlying these disorders. Kramer and collea-
gues,[18] for example, found that observed gender
differences in a number of internalizing and externalizing
disorders became statistically insignificant when con-
trols were included for latent internalizing and
externalizing dimensions. Although the use of latent
variable models in this way is only in its infancy,
evidence such as this has the potential to be very
valuable in distinguishing between specific and non-
specific risk factors.
One obvious application of this sort involves
focusing on the development of comorbidity itself.
In particular, while the cross-sectional structure of
comorbidity has been examined in a number of studies,
we are unaware of attempts to investigate the role of
latent dimensions in accounting for the development of
comorbidity. Several studies of comorbidity used
longitudinal data to determine whether the structure
of internalizing and externalizing disorders is stable
over time,[9,15,16] but none investigated whether
the presumed underlying structure accounts for the
associations between temporally primary disorders
and subsequent first onset of comorbid disorders.
A number of other longitudinal studies examined
temporal progression[19–22] or sequencing[23–27] bet-
ween earlier and later mental disorders, documenting
strong persistence of individual disorders over time and
significant predictive associations between some but
not other temporally primary and later disorders. For
example, Fergusson and colleagues[19] found that
childhood conduct disorder but not ADHD predicted
subsequent onset of substance disorders, while Beesdo
et al. found that temporally primary social anxiety
disorder predicted subsequent onset and persistence of
major depression (MD).[28] None of these studies,
though, investigated the extent to which associations of
earlier disorders with onset of later disorders were
mediated by latent variables. Such an analysis could be
very useful in identifying potentially modifiable risk
pathways.[29,30]
The methodology used up to now to study latent
variable associations underlying the structure of comor-
bidity are too inflexible to study the development of
comorbidity, as the latter requires the use of survival
analysis methods in which temporally primary dis-
orders are time-varying covariates. We consequently
developed a new method to study the mediating effects
of latent variables in accounting for the development of
comorbidity. This method was used to analyze data in
the National Comorbidity Survey (NCS) and the
WHO World Mental Health (WMH) Surveys. The
method is described in the current report. Although
analysis is still underway, broad preliminary findings
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MATERIALS AND METHODS
SAMPLES
The method described here was applied to three surveys in the NCS
family of surveys: the NCS-R, NCS-2, and NCS-A. The NCS-R
(National Comorbidity Survey Replication) is a national household
survey of the prevalence and correlates of DSM-IV[31] mental disorders
among English-speaking adults in the continental US carried out
between 2001 and 2003. A total of 9,282 adults (ages 181)w e r e
interviewed face-to-face. The response rate was 70.9%. Informed
consent was obtained before interviewing respondents. Respondents
were given a $50 incentive for participation. A probability subsample of
hard-to-recruit predesignated respondents was administered a brief
telephone nonrespondent survey (for a $100 incentive), results of
which were used to weigh the main sample for nonresponse bias. The
Human subjects committees of Harvard Medical School and the
University of Michigan approved procedures for recruitment, consent,
and protection of subjects. NCS-R design, field, and weighing
procedures are described in more detail elsewhere.[32]
The NCS-2 is a panel sample obtained by interviewing respondents
in the baseline NCS[33] a decade after the initial 1990 to 2002
assessment. The baseline NCS was a nationally representative US
household survey of 8,098 respondents aged 15–54. The response rate
was 82.4%. Further details about the NCS design and weighing are
reported elsewhere.[33] NCS-2 sought to trace and re-interview an
enriched probability subsample of 5,877 NCS respondents, of whom
5,463 were successfully traced and 5,001 re-interviewed (of the
remainder, 166 were deceased and the other 710 either not traced or
refused to be interviewed), for a conditional response rate of 87.6%.
A propensity score adjustment weight[34] corrected for baseline
discrepancies between the full NCS and the NCS-2.
The NCS-A is a face-to-face survey of adolescents aged 13–17
administered between February 2001 and January 2004 in a dual-
frame sample of the continental US.[35,36] An NCS-A household
sample is made up of 904 adolescents from households in the NCS-R
(86.8% adolescent response rate). An NCS-A school sample is made
up of 9,244 adolescents from a sample of schools in the NCS-R
counties (82.6% adolescent response rate). One parent or surrogate
(henceforth referred to as a parent) was asked to complete a self-
administered questionnaire (SAQ) about each participating adoles-
cent. The SAQ conditional response rate was 82.5–83.7% in the
household–school samples. A total of 6,483 adolescent–parent pairs
provided data on both adolescent interviews and parent SAQs.
DIAGNOSTIC ASSESSMENT
Diagnoses in the NCS-2, NCS-R, and NCS-A were based on the
WHO Composite International Diagnostic Interview (CIDI),[37] a
fully structured lay-administered interview that generates diagnoses
according to both ICD-10 and DSM-IV criteria. The 18 lifetime
diagnoses considered here include mood disorders (bipolar I–II and
subthreshold disorder [BPD], and major depressive episode/dysthymia),
anxiety disorders (agoraphobia with or without panic disorder (PD),
GAD, PD with or without agoraphobia, post-traumatic stress
disorder [PTSD], separation anxiety disorder, social phobia, and
specific phobia [SP]), behavior disorders (attention-deficit disorder,
referred to below as AD; hyperactivity disorder, referred to below as
HD; conduct disorder with covert symptoms [e.g., lying, shoplifting;
referred to below as CD1]); conduct disorder with overt symptoms
[e.g., bullying, being physically cruel to people, referred to below as
CD2]; intermittent explosive disorder [IED]; oppositional-defiant
disorder [ODD]), and substance disorders (alcohol abuse with or
without dependence, drug abuse with or without dependence).
Lifetime prevalence and age-of-onset (AOO) were retrospectively
assessed in the NCS and NCS-A, while NCS-2 respondents were
administered an expanded version of the baseline interview that
assessed onset and course of disorders between the two surveys. As
detailed elsewhere,[38,39] blinded clinical reappraisal interviews found
generally good concordance between DSM-IV diagnoses based on
the CIDI and those based on the Structured Clinical Interview for
DSM-IV[40] in the NCS-2 and NCS-R and with the Schedule for
Affective Disorders and Schizophrenia for School-Age Children
Lifetime Version[41] in the NCS-A. Organic exclusions but not
diagnostic hierarchy rules were used in making diagnoses. The CIDI
included retrospective disorder AOO reports based on a special
question sequence that has been shown experimentally to improve
recall accuracy.[42] These were used to date lifetime disorder AOO
retrospectively in all surveys. The NCS-2, in addition, has
prospective data on order of onset obtained from the two-waves of
panel interviews.
ANALYSIS METHODS
Defining the content of the latent variables. Exploratory
principal axis tetrachoric factor analysis with promax rotation was used
to examine bivariate comorbidity to determine whether the same
structure was found as in previous studies of the structure of
comorbidity among the NCS disorders.[3,43] Clear internalizing
and externalizing dimensions were found in all surveys. This structure
was very similar to that found in a comparison of the NCS-R data
with parallel data obtained in 13 other countries in the WHO
WMH surveys.[44] In addition, evidence for subfactors of fear disorders
(panic, phobia, and IED) and distress disorders (depression, GAD,
PTSD, and SAD) within the internalizing factor and for subfactors
of behavior disorders and substance disorders within the externa-
lizing factor was found in the NCS-A, although not in the NCS-2 or
NCS-R.
Predicting onset of comorbidity. Discrete-time survival
analysis[45] with person-year as the unit of analysis and a logistic link
function[46] was then used to study associations of temporally primary
lifetime disorders with subsequent first onset of later disorders. Each
model predicted first onset of one of the 18 DSM-IV/CIDI disorders
from information about prior lifetime occurrence of the other 17
disorders, which were treated as time-varying covariates, controlling
for respondent age, sex, and race/ethnicity. As noted above, retro-
spective AOO reports were used to define the predictor disorders as
time varying and to define age of onset of the outcome disorders. In
the NCS-2, which is a panel sample, results were replicated and
compared for prospective assessments (i.e., disorders with first
lifetime onsets in the decade between T1 and T2 that were reported
for the first time at T2 predicted by lifetime disorders reported at T1)
and for pooled prospective and retrospective assessments (i.e., adding
to the prospective data information about associations between
temporally primary and secondary lifetime disorders that were both
reported at T1 or were both reported at T2 to have occurred in the
decade between T1 and T2) in an effort to determine whether
retrospective recall bias led to any distortion in results. As there were
18 disorders in these analyses, a total of 306 coefficients (1817)
were estimated (first onset of each disorder predicted by prior lifetime
occurrence of the 17 other disorders).
Estimating the mediating effects of latent variables. We
then estimated a latent variable model that constrained these 306
coefficients by assuming that they are all mediated by time-varying
latent internalizing and externalizing variables or, in the case of the
NCS-A, latent fear, distress, behavior, and substance disorder variables.
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sense that the latent variable model used a smaller number of
independent coefficients to reproduce these same associations. This is
easiest to grasp by comparing a visual representation of the model for
the associations involving observed variables (Fig. 1), which has 306
coefficients, with a representation of the model for the two-factor latent
internalizing-externalizing model (Fig. 1), which has 36 independent
coefficients. The latter includes 10 coefficients (one of which is
nonindependent because the 10 coefficients together perfectly predict
the time t latent variable) for 10 time t lifetime internalizing disorders
predicting the time t latent internalizing variable, 8 coefficients (one of
which is nonindependent because the 8 coefficients together perfectly
predict the time t latent variable) for the 8 time t lifetime externalizing
disorders predicting the time t latent externalizing variable, 4
coefficients (two of which are nonindependent because the pair of
time t latent variables perfectly predict each of the two time t11 latent
variables) for the time t latent internalizing and externalizing variables
predicting the time t11 latent internalizing and externalizing variables,
10 coefficients for the time t11 latent internalizing variable predicting
first onsets of the 10 time t11 internalizing disorders, and 8 coefficients
for the time t11 latent externalizing variable predicting first onsets of
the 8 time t11 externalizing disorders. Using similar logic, there are 44
independent coefficients in the four-factor model of fear, distress,
behavior, and substance disorders.
It is important to recognize that these constrained latent variable
models cannot be estimated using the standard covariance structure
analysis programs used in previous studies of the structure of
comorbidity, as the number of person-years in the survival analysis
data files varies across the 18 outcomes. It is also important to note
that identification in this model was different than in the conven-
tional model in that we did not assume the structure assumed in a
factor analysis model; that is, a structure in which the latent variables
cause the observed disorders and the prediction errors for the
observed disorders are assumed to be conditionally independent.
Instead, we assumed that the observed disorders are the predictors of
the latent variables and that the observed disorders can be
exogenously correlated. The basic notion here is that the latent
variables, which are referred to as canonical variables,[47] represent
common pathways by which the predictors influence multiple
outcomes, with the identification of the common pathways indicated
by consistencies in ratios of metric regression coefficients for the
predictors across the range of outcomes.
Conventional canonical analysis is carried out using matrix
manipulation methods similar to those used in the confirmatory
factor analysis models that have previously been used to study the
structure of comorbidity.[48] The situation is much more complex,
though, when we are dealing with survival models across a range of
outcomes that have first onsets that vary from person to person and
year to year. As a result, a special approach was needed to estimate the
variant on the standard canonical model used in our analysis.
Specifically, iterative methods were used to estimate the coefficients
in the model by considering each of the three main parts of the model
separately (time t observed variables predicting time t latent variables,
time t latent variables predicting time t11 latent variables, time t11
latent variables predicting time t11 observed variables), estimating
the coefficients only in one of these three parts at a time while fixing
the coefficients in the other two parts of the model to their values
in the most recent iteration, and then repeating this process
sequentially until the estimates converged. This procedure yields
maximum-likelihood estimates of the model parameters. A SAS
macro was written to implement these procedures.[49] Once the
coefficients in the model were estimated, a likelihood-ratio w
2 test
was used to compare the fit of the latent variable model with the
observed variable model with 270 (306–36) degrees of freedom in the
case of the two-factor model and 264 (306–44) degrees of freedom in
the case of the four-factor model.
Importantly, the latent variable model provided a better fit than the
observed variable model in all three datasets based on a wide range of
conventional fit indices. This was also true when we applied the same
approach to the analysis of the pooled cross-national dataset in the
WMH surveys.[44] This then led to the issue of how to interpret the
coefficients in the three-part latent variable models. This is a rather
complex matter in that none of the individual coefficients can be
interpreted directly, as it is the products of the coefficients that are
determined rather than the coefficients themselves in the model. For
example, referring to Figure 2, the product of coefficients a1b1c4
is the estimated survival coefficient for the association between
temporally primary internalizing disorder I1 (which, for example,
might be SP) and the subsequent first onset of internalizing disorder
I4 (which, for example, might be major depressive episode). However,
if all an coefficients were multiplied by 2 and all bn coefficients were
divided by 2, this product would be the same. As a result, we need to
consider how to make sense of these component coefficients. The
focus of this report is on how to do that and on the substantive
Figure 1. Schematic of the multivariate observed variable model. Only two observed lifetime time t internalizing disorders (e.g., i1t
represents internalizing disorder 1 at time t) and externalizing disorders along with only one observed internalizing and one observed
externalizing disorder at time t11 are shown to simplify the presentation, but there were 10 observed lifetime internalizing and 8
observed externalizing disorders in the actual survival model at each time point. First onset of each of these 18 disorders between times t
and t11 was predicted by prior lifetime history of the other 17 disorders as of time t. Estimation was made in 18 separate survival
equations, each with 17 predictors for prior history of the other disorders, for a total of 306 (1817) pair-wise time-lagged associations
between earlier and later mental disorders. The 17 predictor disorders were treated as time-varying covariates in a discrete-time
(person-year) survival framework. Controls were also included for respondent age at interview, sex, person-year, and country.
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now in the analysis of the NCS-2 and NCS-A data.
Examining residual effects. We also wanted to go beyond
the global comparison of latent and observed variable models to
determine whether any of the 306 pair-wise associations among
predictor disorders and outcome disorders remained significant even
after controlling for the latent variables. In other words, we were
interested in determining whether there were any particularly strong
associations between a specific temporally prior disorder and a later
comorbid disorder that were not explained by the general internalizing
and externalizing pathways. This was done by generating empirical
estimates of the time t latent variables from the an coefficients in the
models and using these as control variables in 306 separate bivariate
survival equations that predicted first onset of each disorder from prior
history of each of the other disorders. One problem in using this
approach, though, is that simple pair-wise significance tests were
inappropriate to evaluate the significance of residual coefficients
because probability of false positives increases as the number of tests
increases. We would expect more than a dozen false positives out of
306 tests using .05-level pair-wise significance tests. A stronger
standard of evidence is needed to prevent this problem from occurring.
The Bonferroni method and its extensions have been developed to
adjust significance levels in pair-wise tests to deal with this problem,[50]
but these are low-power tests that make it difficult to detect true
associations unless they are very large.[51] To address this problem,
we used an internal subsampling strategy to pinpoint particular pair-
wise associations for further investigation. Specifically, we generated
the bivariate survival models in the NCS-2 separately among men and
women and at four independent life course stages (childhood: aged
4–12; adolescence: aged 13–19; young adulthood: aged 20–29; middle
adulthood: aged 30–44). We considered a given pair-wise association
substantively significant only if it was statistically significant at the .05
level both in the total sample and either among both males and females
or in at least two independent subsamples with consistent sign patterns
and odds-ratios (exponentiated survival coefficients) either greater than
or equal to 2.0 or less than or equal to 0.5. In the NCS-A, where we
had a restricted age range (13–17), we only considered consistency of
results by gender. As the NCS-2 and NCS-A data are both clustered
and weighed, the design-based method of jackknife repeated replica-
tions (JRR)[52] was used to calculate standard errors and assess
statistical significance. A SAS macro was used for this purpose.[49]
RESULTS
BIVARIATE AND MULTIVARIATE
ASSOCIATIONS BETWEEN EARLIER AND
LATER DISORDERS
As noted above, data analysis is still in progress and
we consequently only provide a general overview of
preliminary results here to illustrate the use of the
method. When we examined the 306 bivariate survival
equations (each with first onset of one of the 18 lifetime
outcome disorders predicted by the prior occurrence of
one of the other 17 disorders), we found well over 90%
to be positive and significant in each of the three
datasets, with most odds ratios (exponentiated survival
coefficients) in the range 2.0–4.0. Within-domain ORs
(e.g., internalizing disorders predicting other interna-
lizing disorders) were generally larger than between-
domain ORs (e.g., internalizing disorders predicting
externalizing disorders). This largely positive pattern
persisted in somewhat attenuated form in the multi-
variate models that included information about time t
history of all other 17 disorders to predict subsequent
first onset of each of the 18 disorders.
MULTIVARIATE ASSOCIATIONS IN THE
LATENT VARIABLE MODEL
As noted above in the section on analysis methods,
the latent variable model fits the observed data better
than did the observed variable model in all three
datasets as indicated by standard measures of compara-
tive model fit.[53] This means that the predicted values
of the 306 survival coefficients generated by the
coefficients in the latent variable models did not, as a
set, differ substantially from the observed values
generated from the 18 unrestricted survival equations.
Given that the latent variable models are much more
Figure 2. Schematic of the multivariate latent variable model. Only two observed lifetime time t internalizing disorders (e.g., i1t represents
internalizing disorder 1 at time t) and externalizing disorders and only two disorders of each set at time t11 are shown to simplify the
presentation, but there were 10 observed lifetime internalizing and 8 observed externalizing disorders in the actual survival model.
First onset of each of these 18 disorders between times t and t11 was predicted by latent internalizing or latent externalizing variables at
time t11 in the NCS-2. There were four rather than two latent variables in the NCS-A. These latent variables, in turn, were predicted by
lifetime history of latent internalizing and externalizing variables as of time t.T h e s et i m et latent variables, finally, were predicted by lifetime
history of observed internalizing or externalizing variables as of time t. Estimation was carried out using a three-part iterative procedure.
See the text for more details. A total of 36 independent associations were estimated in the NCS-2 two-variable model, 270 fewer than in the
model for associations among observed disorders. The number of independent associations was 44 in the four-variable latent variable model
for the NCS-A data. As in the earlier observed variable model, the predictor disorders were treated as time-varying covariates in a discrete-
time (person-year) survival framework and controls were included for respondent age at interview, sex, person-year, and country.
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makes sense to focus on the former rather than the
latter in interpreting the data. A difficulty in doing this,
though, was noted above in the section on analysis
methods: that none of the individual coefficients in the
latent variable models can be interpreted directly
because of the fact that although the products of the
coefficients are determined, the individual values of the
coefficients are arbitrary.
Three observations are especially useful in making
sense of the latent variable coefficients in the face of
this arbitrary nature of the individual coefficients: first,
the time t latent variables represent weighed compo-
sites of the time t predictor disorders; second, the
associations between the time t latent variables and the
time t11 latent variables represent differential multi-
pliers of the effects of the disorders in the time t
composites on what has been referred to in the
literature[25] as homotypic (i.e., within-composite) and
heterotypic (i.e., between-composite) comorbidity;
and, third, the differential importance of the time t
composites in predicting the diverse outcomes is
represented by the product of the b and c coefficients.
We use these three observations to organize our
discussion of the latent variable results in the next
three subsections.
TIME t LATENT VARIABLES AS WEIGHED
COMPOSITES
Inspection of Figure 2 makes it clear that the time t
latent variables represent weighed composites of the
time t predictor disorders. For example, latent variable
It is defined as the sum of the a coefficients for the
lifetime internalizing disorders that the respondent has
as of time t. The weights define the relative importance
of the predictor disorders (as given by their survival
coefficients in predicting the time t latent variables) in
predicting the outcome disorders. The model assumes
that this relative importance is constant across all
outcomes, an assumption that is shown to be consistent
with the data by the fact that the model provides a good
fit to the observed data. This being the case, the most
useful metric in which to consider the a coefficients is
one that highlights the disorders with the largest
coefficients in each set and that describes the coeffi-
cients associated with the other disorders as fractions of
these largest coefficients.
Preliminary results regarding the relative magnitude
of a coefficients show a number of important consis-
tencies across surveys. For one, temporally primary MD
is consistently much more important than GAD in
predicting onset of later disorders in all the surveys. In a
similar way, temporally primary SP is consistently the
most important fear disorder and PD consistently less
important in predicting onset of later disorders in all
surveys. These results are true despite the existence of
high comorbidities between MD and GAD and between
SP and PD. Furthermore, in all surveys substance
disorders are by far the least important externalizing
disorders in predicting onset of later disorders. Finally,
between-disorder variation in the size of a coefficients in
all surveys is considerably greater for internalizing than
externalizing disorders. In particular, the coefficients
associated with temporally primary ADHD, conduct
disorder, and ODD are fairly comparable in magnitude,
suggesting that these disorders have similar predictive
effects, whereas the predictive effects of internalizing
disorders are more variable.
DIFFERENTIAL PREDICTION OF
HOMOTYPIC AND HETEROTYPIC
COMORBIDITY
Inspection of Figure 2 makes it clear that the
coefficients linking the time t and time t11 latent
variables (the b coefficients) are differential multipliers
of the associations between time t predictor disorders
in different composites and the subsequent onset of
secondary disorders in these same and different
composites. For example, if we standardize a coeffi-
cients and c coefficients to have weighed (by prevalence
of disorders) means of 1.0, the resulting values of b
coefficients can be interpreted as averages of the
survival coefficients linking temporally primary dis-
orders in a given time t composite to subsequent first
onset of disorders in a given time t11 composite. Based
on the results of previous studies,[25,27] we would expect
these coefficients to be larger in predicting homotypic
than heterotypic associations. This is, in fact, what
we found in all the samples. Temporally primary
internalizing disorders were more powerful predictors
of subsequent onset of other internalizing disorders
than of externalizing, while temporally primary
externalizing disorders were more powerful predictors
of subsequent onset of other externalizing disorders
than of internalizing disorders. However, the specificity
was greater for externalizing than internalizing dis-
orders. That is, externalizing disorders were much
more powerfully predicted by earlier externalizing than
internalizing disorders, whereas internalizing disorders
were predicted only slightly more by earlier internali-
zing than externalizing disorders.
DIFFERENTIAL PREDICTION OF TIME t11
DISORDERS
Comparison of the c coefficients within each
composite tells us about the differential effects of the
time t composites on first onset of the time t11
disorders. A striking finding in preliminary analyses of
all three datasets is that the c coefficients are
remarkably similar in magnitude within each compo-
site. This means that odds of onset of all internalizing
disorders are predicted with similar strength by prior
history of other disorders as of time t and that all
externalizing disorders are predicted with similar
strength (i.e., magnitude of the survival coefficients
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this regard that the c coefficients are much less variable
in magnitude than the a coefficients, which means that
the disorders considered here differ much more in their
importance as predictors of later disorders than as
consequences of earlier disorders.
The issue of whether time t11 internalizing disorders
are predicted as strongly as time t11 externalizing
disorders cannot be evaluated by looking only at the c
coefficients, as these cross-composite comparative pre-
dictive associations are a function of the product of the b
coefficients and the c coefficients. Give that, as noted
above, the b coefficients are stronger in predicting
homotypic than heterotypic comorbidity, it follows that
the survival coefficients linking the time t latent
composites with the time t11 disorders will be stronger
for the time t internalizing composite than the time t
externalizing composite predicting the time t11 internal-
izing disorder and vice versa in predicting the time t11
externalizing disorders.
VARIATION OVER THE LIFE COURSE
An important consideration in evaluating the results
reported so far is that they were based on analyses that
assume consistency of coefficients over the entire life
course. It is not clear that this assumption makes sense,
especially given the fact that the AOO distributions of
the disorders considered here differ markedly from the
typically very early AOO of some disorders (e.g.,
ADHD, SP, and separation anxiety disorder) to
comparatively late AOO of other disorders (e.g., MD,
GAD, and substance use disorders).[54,55] In order to
investigate this issue, we replicated the analysis in the
prospective NCS-2 data in subsamples of person-years
defined by life course stage (childhood: aged 4–12;
adolescence: 13–24; young adulthood: 25–39; later
adulthood: 401). Results were clear in showing that
predictive associations exist in all the age ranges
studied, that these associations generally decrease in
magnitude over the life course, and that the associa-
tions involving prediction of behavior disorders are
very unstable beyond adolescence due to the fact that
the vast majority of behavior disorders have their first
onsets in childhood or adolescence.
Perhaps the most striking aspect of these disaggre-
gated analyses is that we found significant predictive
associations between temporally primary behavior
disorders and the subsequent first onset of internalizing
disorders even in later adulthood despite the fact that
other NCS-A analyses showed that the majority of
these behavior disorders remitted either in adolescence
or early adulthood. Further investigation of this pattern
showed that it was due to prior history of remitted
behavior disorders predicting first onset of distress
disorders in later adulthood. We did not control in
these analyses for the various adverse consequences of
prior behavior disorders that might still be present in
later adulthood (e.g., low educational attainment and
consequent low employment status, low earnings, and
high financial distress) and still exert an active effect in
promoting first onset of other disorders. Nor did we
investigate the possibility that subthreshold manifesta-
tions of the ostensibly remitted behavior disorders
continued to exist in adulthood and accounted for the
predictive effects found in these analyses. As a result,
we have no firm basis for saying that some latent
predisposition for behavior disorders still present in
adulthood promotes onset of later disorders even when
the behavior disorders remit. Further analyses aimed at
discovering and documenting the effects of intervening
adverse consequences are needed to advance our
understanding of this data pattern.
RESIDUAL ASSOCIATIONS BETWEEN
SPECIFIC PAIRS OF DISORDERS
About a dozen residual (i.e., controlling the latent
variables) pair-wise time-lagged associations between
prior lifetime disorders and subsequent first onset of
later disorders passed our test of statistical significance
in one or more of the surveys. Most of these involved
either within-disorder reciprocal effects (e.g., covert
conduct disorder predicting overt conduct disorder),
well-known linked pairs of disorders (e.g., panic
predicting agoraphobia and depression predicting
GAD), or possible diagnostic confusions (e.g., agor-
aphobia predicting bipolar disorder). In the NCS-A, in
comparison, virtually all these significant residual
associations disappeared when we estimated a more
complex latent variable model that allowed for four
dimensions (distress, fear/anger, behavior, and sub-
stance). We attribute this to the fact that the NCS-A
model was more fine-grained than the model used in
the other datasets. There are hints in the data of a small
number of other potentially important residual associa-
tions existing that are substantively meaningful, but
they appear to be few in number and their stability is
unclear from the analyses we have carried out so far.
DISCUSSION
Four limitations need to be noted in interpreting the
above results. First, diagnoses were based on fully
structured lay interviews with the CIDI. The CIDI
typically produces more reliable diagnoses than those
based on semi-structured clinical interviews[56] and
their prevalence estimates typically correspond well
with those based on clinical reappraisal interviews.[57]
However, fully structured interviews, unlike semi-
structured clinical interviews, are unable to clarify
symptom responses or check questions across disorders
to facilitate differential diagnosis, potentially leading to
inflated estimates of comorbidity. As comorbidity is the
focus of the current analysis, this is an especially
important limitation that should be kept in mind when
interpreting results. Second, lifetime diagnoses were
based on retrospective reports rather than prospective
35 Research Article: Latent Variables in Developing Comorbidity
Depression and Anxietydata, probably leading to recall bias that under-
estimated prevalence[58] and distorted AOO esti-
mates[59] despite special memory-priming methods
used in both surveys.[42] Third, the models were based
on the simplifying assumption that the time-lagged
associations among mental disorders are additive.
Fourth, the models assumed that there are no
differential predictive associations related to age of
onset or time since onset of the temporally primary
disorders. More in-depth analyses to investigate these
assumptions go beyond the scope of this preliminary
report.
In the context of these limitations, our finding of a
two-factor internalizing–externalizing structure among
the DSM-IV disorders is consistent with previous
research,[3–5,7–9] but the NCS-2 and NCS-R results do
not support the distinction found in the NCS-A and
some other previous studies between distress (e.g.,
depression, GAD, and PTSD) and fear (i.e., panic and
phobias) disorders within the internalizing domain.
Others also failed to find a distinction between distress
and fear disorders.[3,4,17] This less differentiated
structure might be due to our focus on lifetime
disorders, whereas 12-month disorders were the focus
of most studies that distinguished distress and fear
disorders. The fact that the more differentiated picture
appears in the NCS-A despite the focus on lifetime
disorders might be due to a greater proportion of
lifetime disorders are being recent disorders in the
studies of youth than adults.
Our finding of significant time-lagged associations
across virtually all pairs of disorders considered here is
broadly consistent with evidence of associations between
earlier and later disorders in previous longitudinal
studies,[19,22–25,27] although most previous studies focused
on prevalent cases whereas we studied first onsets. We
found, again consistent with previous studies, stronger
and more consistent time-lagged associations within
(homotypic) than between (heterotypic) the internalizing
and externalizing domains. However, again like previous
studies, we also found significant between-domain time-
lagged associations.[25,27]
Our analysis then went beyond previous studies to
investigate the role of latent variables in the develop-
ment of comorbidity. We showed that the vast majority
of the 306 pair-wise time-lagged associations among
the 18 disorders considered here can be explained by
a model that assumes the existence of mediating
latent internalizing and externalizing variables.
The temporally primary disorders constituting the
mediating predictor variables vary substantially in
importance in predicting secondary disorders, but the
good fit of the model shows that the relative
importance of these disorders is quite consistent in
predicting a wide range of secondary disorders. This
suggests that common pathways are involved in these
many predictive associations.
Despite the stability of relative importance of
predictor disorders within domains, we also found
significant between-domain variation in strength of
prediction, with consistently stronger predictive asso-
ciations within (homotypic) than between (heterotypic)
domains. However, temporally primary externalizing
disorders were more consistently significant predictors
of the subsequent onset of internalizing disorders, with
predictive effects nearly as large as those of temporally
primary internalizing disorders, than temporally
primary internalizing disorders were in predicting
subsequent onset of externalizing disorders.
Despite the good fit of the latent variable model, we
found a number of significant residual associations
between particular pairs of temporally primary and
secondary disorders. However, these residual associa-
tions were much more common in the NCS-2 and
NCS-R data, where the best-fitting model assumed the
existence of two latent variables (internalizing and
externalizing) than in the NCS-A data, where the best-
fitting model assumed the existence of four latent
variables (fear, distress, behavior, and substance). This
raises the possibility that the residual associations
represent traces of more differentiated dimensions
underlying internalizing and externalizing disorders.
Some of the significant residual associations found in
the data are quite intriguing and cannot be accounted
for by a simple division of internalizing disorders into
separate fear and distress subdomains or externalizing
disorders into behavior and substance domains. For
example, a stable negative association was found
between temporally primary IED and subsequent drug
abuse after controlling for scores on the latent
internalizing disorder variable. This negative associa-
tion could be due to externalizing disorders being made
up of multiple dimensions, one or more of which is
significantly more strongly related to drug abuse than
to IED. Consistent with this possibility, evidence exists
that multiple dimensions account for associations
among externalizing disorders[60] and that these under-
lying dimensions are somewhat different for impulsive
aggression (i.e., IED) than substance abuse, with
sensation seeking, risk taking, and antisocial person-
ality more strongly related to substance abuse than to
impulsive aggression, and global psychopathology
more strongly related to impulsive aggression than to
substance abuse.[61,62] A more differentiated latent
variable model that includes these externalizing sub-
dimensions or a model that includes explicit measures
of these predispositions might explain the negative
association between IED and subsequent drug abuse in
our less differentiated latent variable model.
It is important to caution, though, that these few
unique significant residual pair-wise associations should
be treated as no more than preliminary due to the
problem of multiple testing even though we required a
high standard of proof to select them. Replication in
other datasets is needed before these associations should
be considered reliable. Furthermore, even if they are
subsequently found to be reliable, their existence should
not deflect attention from our main finding: the
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306 disorder-pairs considered in the three datasets are
likely due to common underlying processes that should
be the focus of future research on the development of
comorbidity. More subtle processes doubtlessly exist,
but are likely to become manifest more clearly by
controlling the effects of the broadly defined latent
variables studied here and searching for consistencies in
residual associations that can be fleshed out in more
focused studies. Implicitly, our results also caution
against interpreting pair-wise associations as unique in
focused analyses of particular disorder pairs without
first demonstrating, as we did here, that they are specific
rather than mere realizations of larger nonspecific
processes involving a larger set of internalizing or
externalizing disorders.
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